Flash FinanceUS
Market closed S&P 5007,549.94+2.35% Nasdaq25,253.14+2.74% Dow 3052,389.75+2.15% Russell 20002,840.81+3.15% Nasdaq-10027,907.62+3.40% MidCap 4003,715.23+3.13% SmallCap 6001,722.37+2.89% VIX19.92-22.31% 10Y Yield4.86+0.10% Close of Nov 09, 2026
AI brief of an SEC Form 8-K · CONMED (CNMD)

CONMED director Martha Aronson resigns from board to become Merit Medical CEO

Neutral Impact 2 of 5 leadership Written later

CONMED director Martha Aronson resigned from the board effective July 7, 2025, to become President and Chief Executive Officer of Merit Medical Systems, Inc. The filing states there were no disagreements between the company and Ms. Aronson. Shareholders should note a board seat is vacated, but the filing gives no replacement details or financial figures.

Key points

  • Martha Aronson resigned from the CONMED Board of Directors effective July 7, 2025.
  • Ms. Aronson is assuming the role of President and CEO at Merit Medical Systems, Inc.
  • The filing states there were no disagreements between the company and Ms. Aronson.
  • Ms. Aronson joined the CONMED Board in February 2016 and previously served as Chair of the Board.

The filing

CompanyCONMED (CNMD)
Form8-K, current report
Filed with the SECJul 7, 2025, 5:05 PM ET
Accession number0001174947-25-000987

Items reported: 5.02 Director / Officer Change7.01 Regulation FD Disclosure

Read the filing on SEC.gov ↗

Written by AI on Nov 8, 2026, 6:58 AM ET, from this filing only. Written later: this filing was briefed after the fact, when past filings were added to the site, so the brief may be read with hindsight; the filing itself is the record of what was known on July 07, 2025.

Briefs are written by AI from the filing text and can contain mistakes — open the filing before acting on anything. Impact (1-5) and tone are the AI's reading of the filing for shareholders, not a price forecast. Not investment advice.